Historical record - last NADAC effective date: 5/19/2021

Product Information

ZENZEDI 20 MG TABLET is a brand (anda) product labeled by Azurity Pharmaceuticals Inc., priced at $7.0423 per EA under NDC 24338085503. Its NADAC has been published 52 times since May 19, 2021.

FDA first approved this application on Oct 25, 2011. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ZENZEDI 20 MG TABLET

Dextroamphetamine Sulfate
$7.0423per EA
High Outlier
DEA Schedule CII

Strength

20 mg/1

NDC

24338085503

Classification

Brand (ANDA)

Dosage Form

TABLET

Route

ORAL

Effective Date

5/19/2021

Active Ingredients

DEXTROAMPHETAMINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090533

FDA Approved

10/25/2011

TE Code

AA

On Market Since

5/1/2014

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for ZENZEDI 20 MG TABLET has been published 52 times since May 19, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$7.0423 per EA
All-time high$7.0423 (May 11, 2022)
All-time low$7.0423 (May 19, 2021)
Median price$7.0423
Average price$7.0423
Largest weekly change0.0% (May 26, 2021)
Weeks tracked52
Tracking sinceMay 19, 2021

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

0.0%

All

0.0%

Last surveyed May 11, 2022 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZENZEDI 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZENZEDI 20 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $7.0423 per EA (NDC 24338085503), effective May 11, 2022.

How has the price of ZENZEDI 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZENZEDI 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since May 19, 2021.

What are the highest and lowest recorded NADAC prices for ZENZEDI 20 MG TABLET?

Since May 19, 2021, the NADAC for ZENZEDI 20 MG TABLET has ranged from a low of $7.0423 (May 19, 2021) to a high of $7.0423 (May 11, 2022), with a median of $7.0423 per EA.

Are there cheaper alternatives to ZENZEDI 20 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMPHETAMINE 20 MG TAB, is $5.3854 per EA — about 24% below ZENZEDI 20 MG TABLET.

Who manufactures ZENZEDI 20 MG TABLET?

ZENZEDI 20 MG TABLET (NDC 24338085503) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand (anda) product.